A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantStefano Sacchi, Luciano Masini, Raffaella Marcheselli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2011Cited by 28
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric surveyGiovanni D’Arena, Vincenzo De Feo, Maria Luigia Vigliotti et al.|Leukemia & lymphoma/Leukemia and lymphoma|2013Cited by 26
A RANDOMIZED PHASE II STUDY (GISL-MM03 TRIAL) WITH ORAL MELPHALAN plus PREDNISONE (MP) VERSUS MELPHALAN, plus PREDNISONE plus THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMAStefano Sacchi, Maura Brugiatelli, Raffaella Marcheselli et al.|IRIS UNIMORE (University of Modena and Reggio Emilia)|2009Cited by 1